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Abstract
Background: The ORF6 protein is one of the eight accessory proteins of the severe acute respiratory syndrome
coronavirus (SARS-CoV). Numerous properties of ORF6 have been documented and this study focuses on two of
these, namely, its ability to suppress the expression of co-transfected expression constructs and its subcellular
localization to vesicular structures.
Results: Using a transient transfection system, ORF6’s ability to suppress the expression of co-transfected
expression constructs was measured in a quantitative manner. While ORF6 does not have a global effect on
protein synthesis, quantitative real-time PCR revealed that it down-regulated the mRNA level of the co-transfected
myc-nsp8 gene. Furthermore, alanine substitution of a diacidic cluster motif (aa53-56) in the ORF6 gene caused a
reduction in the suppression of expression of co-transfected myc-nsp8 gene. Our previous study revealed that
ORF6 localized to vesicular structures in SARS-CoV infected Vero E6 cells. Here, ORF6 was observed to be localized
to similar vesicular structures in Vero E6 cells which have been transiently transfected with a mammalian
expression plasmid encoding for untagged ORF6. ORF6 showed partial colocalization with cellular proteins CD63
and Lamp1, suggesting that the vesicular structures may be a subpopulation of endosomal/lysosomal vesicles. The
alanine substitution of the diacidic cluster motif also altered the subcellular localization of the ORF6 protein,
indicating a potential relationship between the subcellular localization of the ORF6 protein and its ability to
suppress the expression of co-transfected expression constructs.
Conclusions: By combining quantitative real-time PCR and transient transfection system, a simple and safe method
is established to measure ORF6’s ability to suppress the expression of co-transfected myc-nsp8. In addition,
immunofluorescence analysis revealed that the subcellular localization of ORF6 when expressed on its own is
similar to that observed in SARS-CoV infected cells. Through the use of these two assays, a putative diacidic motif
in the ORF6 protein was found to influence its subcellular localization and ability to suppress the expression of co-
transfected expression constructs.
Background
An outbreak of Severe Acute Respiratory Syndrome
(SARS) in 2003 which carried with it a fatality rate of
8% was traced to a novel coronavirus dubbed the SARS
Coronavirus (SARS-CoV). This novel coronavirus was
eventually classified as a Group IIb coronavirus, a subset
of the Group II coronaviruses. The subclassification was,
in part, due to the presence of several accessory genes
in the coronavirus which have no known homologs
within the family Coronaviridae. These accessory genes
have been the subject of study by many groups (for
reviews, see 1 and 2) and have been assigned a plethora
of physical characteristics and intracellular functions.
Most importantly, almost all of these accessory genes
have been shown to be dispensable for viral replication
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© 2011 Gunalan et alin cell culture, with the exception of the 3a accessory
gene (3). It has been suggested these accessory genes
have subtle effects on SARS-CoV replication and may
be more important for viral replication or pathogenesis
in vivo.
One of these accessory genes, ORF6, encodes for a
~7kDa protein with a hydrophobic N-terminal and that
has been suggested to have a N-endo-C-endo conforma-
tion (4). Several groups have undertaken to characterize
the protein product of the ORF6 gene and found that it
interacts with the nsp8 protein from the SARS replicase
complex (5), is able to increase infection titer during
early infection at low multiplicity of infection (6),
increase the rate of cellular gene synthesis (7), inhibit
interferon production (8), and inhibit the nuclear translo-
cation of STAT1 by interacting with karyopherin a2( 9 ) .
Most recently, the ORF6 protein has been suggested to
induce intracellular membrane rearrangements resulting
in a vesicular population in the infected cell which could
possibly serve some role in increasing replication (10).
Such virus-induced or virus associated vesicles have pre-
viously been shown in other viral infections, such as pro-
tein trafficking in Herpes simplex virus (11) and Sendai
virus (12). Members of the coronavirus family have been
shown by several groups to also utilize vesicular struc-
tures within the infected cell; most of these studies sug-
gest that vesicles play a role in viral replication (13-16).
We have previously shown that the ORF6 protein
colocalizes with Lamp1-positive vesicles in SARS-CoV
infection (5) and also with the nsp8 protein in the same
set of infected cells, indicating a possible role for the
ORF6 protein in the replicative process of SARS-CoV.
H o w e v e r ,t h e r eh a sb e e n ,t od a t e ,l i t t l ew o r kd o n et o
link the subcellular localization of the ORF6 protein to
its known functions. Gallagher and co-workers have
shown that the ability of ORF6 to impede nuclear trans-
location resulted in the suppression of expression of
transgenes from co-transfected expression constructs if
these need transcription in the nucleus (17). Using this
knowledge, a simple co-transfection system and alanine
substitution mutants in the ORF6 gene are used here to
determine regions of the ORF6 protein that modulate
its ability to suppress the expression of co-transfected
myc-nsp8. The subcellular localization of these mutants
is then examined by immunofluorescence experiments
and compared to that of wildtype ORF6.
Methods
Cells, Plasmids and Antibodies
Vero E6 cells were obtained from ATCC, and cultured
in DMEM (Invitrogen) supplemented with 10% FBS
(Gibco) and penicillin/streptomycin (Sigma). Cells were
cultured in a 37°C incubator with 5% CO2. ORF6 was
cloned into the pXJ3’HA vector (T. Leung, Institute of
Molecular and Cell Biology, Singapore, personal com-
munication) using the sites BamHI and XhoI with a stop
codon to create pXJ3’-ORF6, expressing an untagged
protein. The nsp8 gene from SARS-CoV was cloned
using BamHI and XhoI sites into pXJ40myc to create
pXJ40myc-nsp8, with an N-terminal myc tag for detec-
tion. GST was cloned into pXJ40flag to create
pXJ40flag-GST, which expresses an N-terminal flag
tagged GST protein. The ORF6A49-52 and ORF6A53-
56 mutants were generated by 2 rounds of PCR: the
first round of PCR was used to generate 5’ and 3’ frag-
ments of ORF6 containing the appropriate alanine sub-
stitutions; these were then amplified into full-length
ORF6 using end primers for the ORF6 gene and cloned
into pXJ3’HA using BamHI and XhoI sites. The follow-
ing antibodies were used in this study: rabbit anti-ORF6
was purchased from Abgent, mouse anti-actin from
Sigma, mouse anti-Lamp1 from Abcam, mouse anti-myc
from Santa Cruz and mouse anti-CD63 was purchased
from Biodesign International.
Immunofluorescence
Vero E6 cells were plated in 60mm dishes containing
coverslips and subsequently transfected with mammalian
expression plasmids relevant to the experiment being
performed. Trasfection was performed using Lipofecta-
mine 2000 (Invitrogen) according the manufacturer’s
instructions. 16 hours after transfection, coverslips were
prepared for immunofluorescence as follows: Fixation
was carried out in 100% methanol for 5 minutes and cov-
erslips were left to dry before being blocked with PBS
containing 1% BSA for 30 minutes. Primary antibody
incubation was carried out in a humidified chamber for 1
hour before coverslips were washed 3 times in blocking
solution. Secondary antibody incubation was then carried
out for an hour in a humidified chamber before the cov-
erslips were washed 3 times. Coverslips were mounted
onto glass slides using a mounting mixture of 70% Fluor-
save (Calbiochem) and 30% Vectashield containing DAPI
(Vector Laboratories). Slides were imaged using a Zeiss
LSM510Meta confocal microscope (Zeiss).
SARS-CoV Infection
Vero E6 cells grown on coverslips were infected with
SARS-CoV Frankfurt strain 1. When the cells showed
75 % cytopathic effects, they were subjected to immuno-
fluorescence as described above. All SARS-CoV infec-
tion work was carried out at the BSL4 facility at the
Swedish Institute for Infectious Disease Control in
Solna, Sweden.
Western Blotting
Vero E6 cells were transfected with relevant plasmids
for each experiment. 16 hours after transfection, cells
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Page 2 of 9were scraped into media before being spun down in a
benchtop centrifuge and washed twice with PBS. After
washes, the cell pellets were resuspended in RIPA buffer
(50 mM Tris (pH 8.0), 150 mM NaCl, 0.5% NP40, 0.5%
deoxycholic acid, 0.005% SDS) and freeze-thawed in
liquid nitrogen 3 times before being spun down at 13K
rpm to remove cellular debris. SDS loading buffer was
added to clarified lysates before being boiled at 100°C
and loaded onto an SDS-PAGE gel for separation. Gels
containing separated lysates were transferred onto
Hybond-C nitrocellulose membranes (Amersham) before
blocking with 5% skimmed milk in PBS-Tween. Antibody
incubations were carried out at 4°C overnight or at room
temperature, with constant rotation. After each incuba-
tion, membranes were washed 3 times for 10 minutes
each with PBS-Tween. Following washes after secondary
antibody incubation, membranes were treated with che-
miluminescent substrate (Thermo) and exposed to film.
Metabolic labeling
Vero E6 cells were transfected with 1 μgo r2 u go f
either pXJ3’-ORF6 or empty vector. 16 hours post trans-
fection, cells were starved using DMEM without L-glu-
tamine, cysteine and methionine (Invitrogen) before
being incubated with 100 μCi of
35S-labelled cysteine
and methionine (Perkin Elmer) diluted in starvation
medium for 30 minutes. At the end of each incubation
period, cells were washed in cold PBS and scraped into
a centrifuge tube and lysed in RIPA buffer. 20 μgo f
each lysed sample was boiled with SDS loading buffer
and PAGE separated before being fixed and dried in a
Model 583 Gel Dryer (Bio-Rad). Dried gels were
e x p o s e dt of i l ma t- 8 0 ° Ct oo b t a i na u t o r a d i o g r a p h .
Quantification of signals was performed using the gel
analysis module in Image J.
Quantitative Realtime PCR
Vero E6 cells were co-transfected with increasing
amounts of pXJ3’- O R F 6( 0-2μg )a n daf i x e da m o u n t
of pXJ40myc-nsp8 (1 μg). For each sample, the total
amount of DNA was normalized to 3 μg by addition of
the empty vector, pXJ3’H A ,w h e nn e c e s s a r y .1 6h o u r s
post-transfection, cells were scraped into media and
spun down in a benchtop centrifuge. Cells were washed
twice with PBS and cell pellets were resuspended with
Trizol reagent (Invitrogen). Trizol samples were mixed
w i t hc h l o r o f o r ma n ds p u nd o w ni nab e n c h t o pc e n t r i -
fuge at 4°C before being processed with an RNeasy Mini
Kit (Qiagen), according to the manufacturer’si n s t r u c -
tions. RNA samples were quantified with a Nanodrop
ND-1000 spectrophotometer (Nanodrop Technologies).
Equal amounts of each RNA sample were then reverse
transcribed using poly d(T)12-18 (Invitrogen) and with
Superscript II reverse transcriptase (Invitrogen),
following manufacturer instructions. Following reverse
transcription, equal amounts of each cDNA sample
were added to a portion of reaction mix (Roche) along
with either of the following primer pairs: SARS-nsp8-F:
5’-TGAATGCTAAATCTGAGTTTGA-3’, SARS-nsp8-R:
5’-CATAGCCTGATCTGCCATCTTTT-3’,G A P D H - F :
5’-GAAGGTGAAGGTCGGAGTC-3’,G A P D H - R :5 ’-
GAAGATGGTGATGGGATTTC-3’ and one of the fol-
lowing probes: SARS-nsp8-P: 5’ 6-FAM-
CGTGATGCTGCCATGCAACGC-BHQ 3’,G A P D H - P :
5’ 6-FAM-CAAGCTTCCCGTTCTCAGCC-BHQ 3’.
Reaction mixes were subjected to quantitative real-time
PCR in a Roche Lightcycler 2.0. Cycle threshold values
obtained for the SARS nsp8 gene were normalized
against those for GAPDH to obtain relative quotients
which were then plotted for increasing amounts of
pXJ3’-ORF6 transfected. Briefly, the Ct for the GAPDH
control was subtracted from the Ct for the nsp8 gene
(ΔCt). The fold changes were then calculated from the
ΔΔCt, which was obtained by subtracting each ΔCt
from the ΔCt obtained when 2 μgo fp X J 3 ’HA vector
was used. Alternatively, quantitative real-time PCR was
carried out using SsoFast EvaGreen SYBR Green Master
mix (Bio-Rad) using the same primers for nsp8 and
GAPDH as listed above; probes were omitted from these
experiments. These reactions were carried out in an ABI
7500Fast Realtime PCR system.
Results
The ORF6 protein exerts an effect on the expression of
transgenes from co-transfected expression constructs
To determine amount of ORF6 required to exert an
effect on the expression of transgenes from co-trans-
fected expression constructs, Vero E6 cells were trans-
fected with 1 μg of pXJmyc-nsp8 alone or with either 1
μg, 2 μgo r3μgo fp X J 3 ’-ORF6 plasmid. Western blot-
ting showed a dose-dependent reduction in the expres-
sion of nsp8, concomitant with an increase in the
expression of ORF6 (Figure 1A). In order to determine
the specificity of this effect, Vero E6 cells were cotrans-
fected with another mammalian expression construct
pXJflag-GST and pXJ3’-ORF6 in the same manner as
previously done with the construct encoding for nsp8.
When titrated against increasing amounts of ORF6 pro-
tein, the flag-tagged GST protein was also observed by
Western Blotting to show reduced levels of expression
in a dose-dependent manner (Figure 1B). Thus, it seems
that ORF6 exerts an effect on the expression of trans-
genes from co-transfected expression constructs regard-
less of the nature of the transgenes. However, when
increasing amounts of GST were titrated against nsp8 in
the same manner, no significant reduction in nsp8
expression was observed, indicating that this effect was
specific to the ORF6 protein (Figure 1C).
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The ORF6 protein has been observed to cause a reduc-
tion in the expression of 2 different proteins, with differ-
ent epitope tags. In order to examine the possibility that
this downregulation could be a global effect, Vero E6
cells were transfected with either empty vector,
pXJ3’HA, or pXJ3’-ORF6, and metabolically labeled with
35S for a period of 30 minutes. Quantification of the sig-
nals in each lane of the resulting autoradiograph was
performed and the readings were normalized to the
reading in the lane from the untransfected cells (Figure
2). When 1 μgo fD N Aw a su s e d ,t h e r ei sas l i g h t
decrease in the total cellular protein synthesis in ORF6
expressing cells when compared to cells which had been
transfected with empty vector. However, almost the
same degrees of decrease in the total cellular protein
synthesis were observed in both pXJ3’HA and pXJ3’-
ORF6 transfected cells when 2 μgo fD N Aw a su s e d .
Hence, the decrease in total cellular protein synthesis
observed seems to be related to the transfection process
rather than the expression of ORF6. This suggests that
the cellular effect of ORF6 is not global.
ORF6 exerts its effect at a transcriptional level
In order to examine the possibility that ORF6 affects the
expression of transgenes from co-transfected expression
constructs via a transcriptional mechanism, Vero E6
cells were transfected with 1 μgo fp X J 4 0 m y c - n s p 8a n d
either 1 μg, 2 μgo fp X J 3 ’-ORF6 or no ORF6 plasmid.
16 hours post-transfection, total RNA was extracted,
reverse transcribed and subjected to quantitative real-
time PCR. Taqman chemistry was used to assay for
nsp8 and GAPDH was used as an endogenous control.
The ΔΔCt method was used to calculate the nsp8
mRNA level with respect to the level in the absence of
ORF6. As shown in Figure 3, ORF6 caused a reduction
in the level of nsp8 mRNA in a dose-dependent manner,
indicating a transcriptional reduction caused by ORF6.
These results suggest that ORF6 is able to exert some
form of transcriptional inhibition, which is seen in the
reduced expression from co-transfected plasmids.
The ORF6 protein localizes to intracellular vesicles
positive for Lamp1 and CD63
It has been previously reported that the SARS-CoV
ORF6 protein localizes to intracellular membranous
compartments, which have been suggested to be
induced by ORF6 itself (10). In agreement, it was
observed in this study that ORF6 localized to vesicular
compartments both in SARS-infected Vero E6 cells and
Vero E6 cells transfected with a plasmid encoding for
the ORF6 protein (Figure 4A). Vero E6 cells were
infected with SARS-CoV and analyzed by immuno-
fluoresence, using an antibody against the ORF6 protein.
ORF6 was observed to localize to a distinct population
of intracellular vesicles in these infected cells (Figure
4A). Following this, a mammalian expression plasmid
pXJ3’-ORF6 was transfected into Vero E6 cells and
Figure 1 ORF6 specifically impedes expression of co-transfectants. Vero E6 cells were co-transfected with mammalian expression plasmids
encoding for ORF6 and nsp8 (A), ORF6 and GST (B) or GST and nsp8 (C). Cells were lysed 16 hours post transfection and subjected to Western
Blot analysis using equal amounts of lysate from each transfection. Blots were stripped post-detection and re-probed with an anti-actin antibody
as a loading control. Similar results were obtained in three independent experiments, and a representative set of data is presented.
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Confocal microscopy showed that the ORF6 protein
localized to a similar population of intracellular vesicles.
In our previous work studying the interaction between
ORF6 and the nsp8 protein of SARS-CoV (5), we
showed a colocalization of ORF6 and Lamp1 in Vero E6
cells infected with the HKU39849 strain of SARS-CoV.
Similarly, there was a significant degree of colocalization
between the Lamp1 and ORF6 in transiently transfected
Vero E6 cells (Figure 4B), indicating that the ORF6-
positive vesicles seen in both infected cells and transi-
ently transfected Vero E6 cells were probably an identi-
cal population of vesicles. This allowed us to then use
pXJ3’-ORF6-transfected Vero E6 cells to further study
the characteristics of this vesicular population. In addi-
tion to Lamp1, CD63 (a marker for late endosomes) was
used to examine the compartmental characteristics of
the vesicles. As shown in Figure 4B, ORF6-positive vesi-
cles coincide significantly with CD63-positive vesicles in
Vero E6 cells. This population of vesicles is therefore a
subset of the late endosomal and lysosomal populations,
and shows that the plasmid system employed here yields
similar colocalization of ORF6 with cellular markers as
seen in previous infection work (5).
Amino Acids 53-56 in ORF6 constitute a putative diacidic
motif which affects the suppression of the expression of
co-transfected myc-nsp8
Using the CBS Prediction Servers (http://www.cbs.dtu.
dk/services/), it was determined that the ORF6 protein
had several putative motifs of interest. Of these, aa49-52
(YSEL) was predicted to be a lysosomal targeting motif
YXXL (18), and aa53-56 (DDEE) bears similarity to a
putative diacidic motif DxE,w h i c hg o v e r n sE Re x p o r t
and subsequent localization to different membranous
compartments (19). These motifs were also predicted by
Netland and co-workers (4). In order to determine the
contribution of these motifs to the function of the
ORF6 protein, alanine substitutions were introduced by
two-step PCR to yield ORF6A49-52, which substituted
four alanine residues for the YSEL region, and
ORF6A53-56, which substituted four alanines for the
DDEE region (Figure 5A).
These alanine substitution mutants were cloned into
the same vector as the wildtype ORF6 gene and titrated
against the nsp8 gene, by co-transfection of Vero E6
cells with plasmids encoding for myc-nsp8 and either
35S label
WB: anti-ORF6
35S label,
total protein
07 06 10 10 04 0.7    0.6    1.0   1.0   0.4
Figure 2 ORF6 expression in Vero E6 cells does not cause a
reduction in total cellular protein. Vero E6 cells were transfected
for 16 hours with increasing amounts of pXJ3’-ORF6 or an empty
vector, pXJ3’HA. Cells were starved of methionine and cysteine for 1
hour and labeled with a mixture of 35S-labelled methionine and
cysteine for 30 minutes, then subjected to SDS-PAGE separation and
autoradiography (lower panel). Quantification of the signals in each
lane of the resulting autoradiograph was performed and the
readings, after normalization to the reading in the lane from the
untransfected cells, are shown at the bottom of the autoradiograph.
A fraction of lysate was subjected to Western Blotting using an
antibody directed against the ORF6 protein (upper panel). Similar
results were obtained in two independent experiments, and a
representative set of data is presented.
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Figure 3 The ORF6 protein exerts a transcriptional effect on
nsp8 expression. Vero E6 cells were co-transfected with 1 μgo f
pXJ40myc-nsp8 and different amount of pXJ3’-ORF6. For each
sample, the total amount of DNA was normalized to 3 μgb y
addition of the empty vector, pXJ3’HA, when necessary. Total RNA
was harvested 16 hours later, reverse transcribed and subjected to
quantitative real-time Taqman PCR using primers and probes
specific to nsp8 and cellular protein, GADPH. Relative quotients
between the resulting Ct values for each sample were calculated
using the ΔΔCt method. Similar results were obtained in three
independent experiments, and a representative set of data is
presented.
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Page 5 of 9wildtype ORF6, ORF6A49-52 or ORF6A53-56. It was
observed that both mutants showed increased levels of
expression compared to wildtype ORF6, and this obser-
vation was reproducible (data not shown). The effect of
ORF6A49-52 mutant on the expression of the nsp8 gene
was similar to wildtype ORF6 (Figure 5B). On the other
hand, the nsp8 expression in the presence of ORF6A53-
56 was higher than that in the presence of wildtype
ORF6 (Figure 5B), which suggest that ORF6A53-56 is
less efficient in suppressing the expression of co-trans-
fected myc-nsp8.
As the difference between wildtype ORF6 and
ORF6A53-56 was subtle, a more quantitative approach
to assay nsp8 expression was deemed necessary. Hence,
Vero E6 cells were transfected in the same manner and
instead RNA was extracted and reverse transcribed and
subjected to SYBR Green QPCR using primers for nsp8.
GAPDH was used as a housekeeping gene in order to
normalize the expression levels seen. When pXJmyc-
nsp8 was co-transfected with 1 μgo fp X J 3 ’-ORF6,
ORF6A49-52 or ORF6A53-56, the levels of nsp8 mRNA
were similar (Figure 5C). However, at 2 μg, the levels of
nsp8 mRNA for both ORF6 mutants were slightly higher
than wild-type ORF6 (Figure 5C). In order to determine
if these differences are statistically significant, 5 indepen-
dent experiments were performed, and the results were
then used to perform a t-test measuring the significance
o ft h ed i f f e r e n c eb e t w e e nnsp8 expression levels when
either 2 μg of wildtype ORF6 or 2 μg of each mutant
were used. The difference in nsp8 expression when co-
transfected with either wildtype ORF6 and ORF6A49-52
is not statistically significant (a two-tailed p-value of
0.08). On the other hand, the difference in nsp8 expres-
sion when co-transfected with either wildtype ORF6 and
ORF6A53-56 is statistically significant (a two-tailed p-
value of 0.01). This indicated that the reduction in the
suppression of the expression of co-transfected myc-
nsp8 by ORF6A53-56 was significant, and therefore that
the putative diacidic motif defined by amino acids 53-56
has a role to play in this ability of the ORF6 protein.
The ORF6A49-52 mutant did not show as high a level
of significance.
Alanine substitutions at amino acids 53-56 alter the
subcellular localization of ORF6
Next, the subcellular localization of ORF6A49-52 and
ORF6A53-56 was compared to wildtype ORF6. Vero E6
cells were transiently transfected with either pXJ3’-
ORF6, pXJ3’-ORF6A49-52 or pXJ3’-ORF6A53-56 and
subjected to immunofluoresence analysis. It was
observed that the localization of ORF6A49-52 was
somewhat similar to wild-type ORF6 with main expres-
sion in distinctive vesicles (Figure 6). However, slightly
more ORF6A49-52 than wildtype ORF6 was found to
spread diffusely throughout the cytoplasm. The
ORF6A53-56 also has some cytoplasmic staining but it
was also observed that this mutant protein localized to
vesicles that were clustered into groups of 3-5 vesicles
to form large aggregates. Careful examination of the
localization of the wildtype protein did not yield similar
anti-ORF6
anti-ORF6
anti-CD63
anti-Lamp1
merge
merge
A anti-ORF6
SARS-CoV 
infected Vero 
E6
Transiently 
transfected 
Vero E6
B
Figure 4 ORF6 expressed from a plasmid adopts a similar subcellular localization to virally expressed ORF6 and colocalizes partially
with CD63 and Lamp1. (A) Vero E6 cells were either transiently transfected with pXJ3’-ORF6 or infected with SARS-CoV. At either 16 hours
post-transfection or at 75% CPE, cells were fixed and processed for immunofluorescence using an antibody directed against the ORF6 protein.
(B) Vero E6 cells, which have been transiently transfected with ORF6, were fixed and stained for antibodies directed against ORF6 and either
Lamp1 or CD63. Similar results were obtained in three independent experiments, and a representative set of data is presented.
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diacidic motif from amino acids 53-56, in addition to
being involved in the suppression of the expression of
co-transfected myc-nsp8, is also involved in the subcel-
lular localization of the ORF6 protein and therefore
these 2 phenomena may be linked.
Discussion
Work done by several groups have shown that the ORF6
protein interacts with the nsp8 primase and localizes to
a lysosomal compartment (5), impedes the nuclear
translocation of STAT1 and other proteins specifically
governed by the importin-ß superfamily (9), is able to
enhance replication of both SARS-CoV (6) and MHV-
JHM (20), induces membrane rearrangements by means
of its C-terminus (10) and induces apoptosis via a JNK-
dependent mechanism (21). Through the use of alanine
substitutions, many of these functions have been attribu-
ted to specific regions of the ORF6 protein.
In this study, we have employed the use of transiently
transfected mammalian expression plasmids encoding
for ORF6 to study its function. We have shown that
ORF6 expressed in our system is functionally similar to
that shown by others, by means of 2 assays. Firstly, the
ORF6 expressed in our system is able to suppress the
expression of a co-transfected CMV promoter-driven
plasmid expressing either the nsp8 protein or GST. Sec-
ondly, the localization of ORF6 expressed via transient
transfection was compared to the localization of virally
expressed ORF6, and both display similar subcellular
localization as well as colocalization to the Lamp1
marker.
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Figure 5 Alanine substitutions in the putative diacidic motif in ORF6 exert an effect on impedance of nsp8 expression. (A) A schematic
of the ORF6 amino acid sequence showing the position of two putative motifs, a lysosomal targeting motif and a diacidic motif. (B) Vero E6
cells were transfected with 1 μg of pXJ40myc-nsp8 and either 0 μg, 1 μg, 2 μg of either pXJ3’-ORF6 (left panel), pXJ3’-ORF6A49-52 (centre
panel) or pXJ3’-ORF6A53-56 (right panel). 16 hours post transfection, cells were harvested, lysed and subjected to Western Blotting using an
antibody directed against either ORF6 or myc-nsp8. Actin was used as a loading control. Similar results were obtained in three independent
experiments, and a representative set of data is presented. (C) Vero E6 cells were similarly transfected as in (A) and total RNA was harvested 16
hours later, reverse transcribed and subjected to SYBR-Green QPCR using specific primers for nsp8, with GAPDH as a housekeeping control.
Relative quotients were calculated and plotted from the Ct values obtained, using the ΔΔCt method. The average values with standard
deviations are plotted and the standard deviations are also shown in parentheses in the x-axis labels. Students’ T-test was performed on selected
results and the p-values are indicated. P < 0.05 was considered statistically significant. Similar results were obtained in five independent
experiments, and a representative set of data is presented.
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Page 7 of 9Using a bioinformatics approach to defining regions of
interest in the ORF6 gene, we have identified 2 regions of
interest, a putative lysosomal targeting motif YSEL
between amino acids 49 to 52 and a putative diacidic
motif DDEE between amino acids 53 to 56 (Figure 5A).
Our results indicate that the putative diacidic motif is
involved in both the suppression of expression of co-
transfected expression constructs by ORF6 as well as its
subcellular localization. While we were not able to com-
pletely restore the expression of co-transfected nsp8 in
our system, the effect on nsp8 mRNA level between wild-
type ORF6 and ORF6A53-56 was nonetheless found to
be significantly different. However, the difference is small
and suggests that the diacidic motif is largely dispensable
for this function of ORF6. In contrast, the putative lyso-
somal targeting motif YSEL does not appear to contri-
bute to these properties of ORF6 and this is consistent
with a recent report that alanine substitution of the
region from amino acids 49 to 53 fails to inhibit the abil-
ity of the protein to impede the nuclear translocation of
STAT1 (9). Also, others have shown that the ORF6 pro-
tein induces membrane rearrangements and that the C-
terminus of the protein is important to this function. Our
results show that the region from amino acids 53 to 56 is
involved in the subcellular localization of the ORF6 pro-
tein, since alanine substitution of this region results in a
clustered-vesicle phenotype that is not observed with
wildtype ORF6. The reason for the difference in the sub-
cellular localization of wild-type ORF6 and ORF6A53-56
mutant is not clear. One possibility is that the substitu-
tions of four acidic residues with alanine residues might
have reduced the solubility of ORF6. Alternatively, the
substitutions may have disrupted the interaction of ORF6
with certain host proteins.
Conclusions
Taking these results together, the putative diacidic motif
in ORF6 seems to be important for two properties of
ORF6, namely its ability to suppress the expression of
co-transfected expression constructs and its subcellular
localization to vesicular structures. The implication of
this is that the 2 functions may be inextricably linked.
However, a cause-effect relationship has yet to be deter-
mined for these functions and in light of our findings,
their relationship to the membrane rearrangements
induced by the ORF6 protein should be examined in
future studies. In addition, while the ability of ORF6 to
suppress the expression of co-transfected expression
constructs, was previously linked to the blockage of
nuclear translocation (17), further experiments are
needed to ascertain if amino acids 53-56 are involved in
regulating the nuclear translocation process.
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